We explore the most common conditions patients are treating with medical cannabis and what that means for doctors, policymakers, and consumers.
Results from NuggMD.com's 2024 Election Poll, revealing insights into cannabis voter proclivities and their potential impact in 2024 voting.
We tested 18 cannabis products from unlicensed shops around California. What we found should concern anyone without access to licensed dispensaries.
To better understand why patient outcomes and state policies are often in conflict, we surveyed 603 medical cannabis patients who were treating neuropathy as a primary or secondary condition.
With the DEA reconsidering restrictions, we wanted to understand how a change in classification would affect consumers. And that starts with seeing which states are most interested in Delta 8.
Polling data from cannabis users makes an iron-clad case for more progressive, not more restrictive, policy if New York’s cannabis market is going to function in a safe, lawful way.
California bill AB 2188 aims to end discrimination against employees who use cannabis outside of the workplace.
A Texas A&M study suggests that heavy marijuana consumption (4+ times per month) may lower the incidence of diabetes in women.